Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Trevi Therapeutics, Inc. (TRVI)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K10-KS-1/A
Net income  -29.2-33.9-32.8-26.8-25.6-12.9
Depreciation and amortization   [+]  0.00.00.00.0
Stock-based compensation    2.41.10.50.2
Change in working capital   [+]  1.11.6-0.60.8
Other operating activities  1.05.00.20.97.43.9
Cash from operations  -28.2-28.9-29.0-23.1-18.3-8.0
   
Capital expenditures  0.20.00.00.0-0.20.0
Purchases of short-term investments  126.2     
Other cash from investing  -233.7     
Cash from investing  -107.40.00.00.0-0.20.0
   
Issuance of common stock, net     65.1  
Option exercises  0.10.00.00.00.0 
Financing costs    -0.1   
Other cash from financing  111.420.816.78.23.621.7
Cash from financing  111.320.816.773.23.621.7
   
Free cash flow  -28.0-28.9-29.0-23.1-18.4-8.0
        Per share (diluted)  ($0.43)($1.27)($1.61)($1.97)($42.15)($18.51)
   
Cash paid for interest  0.60.60.2 0.2 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy